Search in:

Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 10

Submit an article Journal homepage

934

Views

CrossRef citations to date

Altmetric

Reviews

Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants

Chi-Un Pae Holy Family Hospital, The Catholic University of Korea College of Medicine, Department of Psychiatry, Bucheon 420717, Kyeonggi-Do, South Korea +82 32 340 2114; +82 2 6442 2789; [email protected]; Duke University Medical Center, Department of Psychiatry and Behavioral Sciences, 2218 Elder Street, DUMC Box 3419, Durham, NC 27705, USA

David M Marks Duke University Medical Center, Department of Psychiatry and Behavioral Sciences, 2218 Elder Street, DUMC Box 3419, Durham, NC 27705, USA

Ashwin A Patkar Duke University Medical Center, Department of Psychiatry and Behavioral Sciences, 2218 Elder Street, DUMC Box 3419, Durham, NC 27705, USA

Prakash S Masand Duke University Medical Center, Department of Psychiatry and Behavioral Sciences, 2218 Elder Street, DUMC Box 3419, Durham, NC 27705, USA

Patrick Luyten University of Leuven, Department of Psychology, Leuven, Belgium

Alessandro Serretti Bologna, Italy

Pages 1561-1570 | Published online: 11 Jun 2009

Cite this article
https://doi.org/10.1517/14656560902988510

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

Maurice-Tison S, Verdoux H, Gay B, et al. How to improve recognition and diagnosis of depressive syndromes using international diagnostic criteria. Br J Gen Pract 1998;48(430):1245-6
PubMed Web of Science ®Google Scholar
Tylee A, Gastpar M, Lepine JP, Mendlewicz J. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee. Int Clin Psychopharmacol 1999;14(3):139-51
PubMed Web of Science ®Google Scholar
Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121(12):953-9
PubMed Web of Science ®Google Scholar
Van Houdenhove B, Luyten P. Customizing treatment of chronic fatigue syndrome and fibromyalgia: the role of perpetuating factors. Psychosomatics 2008;49(6):470-7
PubMed Web of Science ®Google Scholar
Van Houdenhove B. Listening to CFS: why we should pay more attention to the story of the patient. J Psychosom Res 2002;52(6):495-9
PubMed Web of Science ®Google Scholar
Carruthers B, Jain A, De Meirleir K, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr 2003;11:7-115
Google Scholar
Harvey SB, Wadsworth M, Wessely S, Hotopf M. The relationship between prior psychiatric disorder and chronic fatigue: evidence from a national birth cohort study. Psychol Med 2008;38(7):933-40
PubMed Web of Science ®Google Scholar
Fuller-Thomson E, Nimigon J. Factors associated with depression among individuals with chronic fatigue syndrome: findings from a nationally representative survey. Fam Pract 2008;25(6):414-22
PubMed Web of Science ®Google Scholar
Harvey SB, Wadsworth M, Wessely S, Hotopf M. Etiology of chronic fatigue syndrome: testing popular hypotheses using a national birth cohort study. Psychosom Med 2008;70(4):488-95
PubMed Web of Science ®Google Scholar
Wagner-Raphael LI, Jason LA, Ferrari JR. Chronic fatigue syndrome, chronic fatigue, and psychiatric disorders: predictors of functional status in a national nursing sample. J Occup Health Psychol 1999;4(1):63-71
PubMedGoogle Scholar
Tiersky LA, Matheis RJ, Deluca J, et al. Functional status, neuropsychological functioning, and mood in chronic fatigue syndrome (CFS): relationship to psychiatric disorder. J Nerv Ment Dis 2003;191(5):324-31
PubMed Web of Science ®Google Scholar
Bentall RP, Powell P, Nye FJ, Edwards RH. Predictors of response to treatment for chronic fatigue syndrome. Br J Psychiatry 2002;181:248-52
PubMed Web of Science ®Google Scholar
Carter BD, Kronenberger WG, Edwards JF, et al. Differential diagnosis of chronic fatigue in children: behavioral and emotional dimensions. J Dev Behav Pediatr 1996;17(1):16-21
PubMed Web of Science ®Google Scholar
Friedberg F, Quick J. Alexithymia in chronic fatigue syndrome: associations with momentary, recall, and retrospective measures of somatic complaints and emotions. Psychosom Med 2007;69(1):54-60
PubMed Web of Science ®Google Scholar
van de Putte EM, Engelbert RH, Kuis W, et al. Alexithymia in adolescents with chronic fatigue syndrome. J Psychosom Res 2007;63(4):377-80
PubMed Web of Science ®Google Scholar
Smith MS, Martin-Herz SP, Womack WM, Marsigan JL. Comparative study of anxiety, depression, somatization, functional disability, and illness attribution in adolescents with chronic fatigue or migraine. Pediatrics 2003;111(4 Pt 1):e376-81
PubMed Web of Science ®Google Scholar
Fossey M, Libman E, Bailes S, et al. Sleep quality and psychological adjustment in chronic fatigue syndrome. J Behav Med 2004;27(6):581-605
PubMed Web of Science ®Google Scholar
Van Houdenhove B, Egle U, Luyten P. The role of life stress in fibromyalgia. Curr Rheumatol Rep 2005;7(5):365-70
PubMedGoogle Scholar
Hartz AJ, Kuhn EM, Bentler SE, et al. Prognostic factors for persons with idiopathic chronic fatigue. Arch Fam Med 1999;8(6):495-501
PubMedGoogle Scholar
Lynch S, Seth R, Montgomery S. Antidepressant therapy in the chronic fatigue syndrome. Br J Gen Pract 1991;41(349):339-42
PubMed Web of Science ®Google Scholar
Smith WR, Noonan C, Buchwald D. Mortality in a cohort of chronically fatigued patients. Psychol Med 2006;36(9):1301-6
PubMed Web of Science ®Google Scholar
Jason LA, Corradi K, Gress S, et al. Causes of death among patients with chronic fatigue syndrome. Health Care Women Int 2006;27(7):615-26
PubMedGoogle Scholar
Ross SD, Estok RP, Frame D, et al. Disability and chronic fatigue syndrome: a focus on function. Arch Intern Med 2004;164(10):1098-107
PubMed Web of Science ®Google Scholar
Andersen MM, Permin H, Albrecht F. Illness and disability in Danish chronic fatigue syndrome patients at diagnosis and 5-year follow-up. J Psychosom Res 2004;56(2):217-29
PubMed Web of Science ®Google Scholar
Morriss RK, Ahmed M, Wearden AJ, et al. The role of depression in pain, psychophysiological syndromes and medically unexplained symptoms associated with chronic fatigue syndrome. J Affect Disord 1999;55(2-3):143-8
PubMed Web of Science ®Google Scholar
Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett 2008;29(3):287-91
PubMed Web of Science ®Google Scholar
Anisman H, Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 2003;35(1):2-11
PubMed Web of Science ®Google Scholar
Maes M. The immunoregulatory effects of antidepressants. Hum Psychopharmacol 2001;16(1):95-103
PubMed Web of Science ®Google Scholar
Kubera M, Lin AH, Kenis G, et al. Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol 2001;21(2):199-206
PubMed Web of Science ®Google Scholar
Theoharides TC, Papaliodis D, Tagen M, et al. Chronic fatigue syndrome, mast cells, and tricyclic antidepressants. J Clin Psychopharmacol 2005;25(6):515-20
PubMed Web of Science ®Google Scholar
Cleare AJ, Miell J, Heap E, et al. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab 2001;86(8):3545-54
PubMed Web of Science ®Google Scholar
Pae CU, Luyten P, Marks DM, et al. The relationship between fibromyalgia and major depressive disorder: a comprehensive review. Curr Med Res Opin 2008;24(8):2359-71
PubMed Web of Science ®Google Scholar
Pae CU, Masand P. Duloxetine: a new psychopharmacologic treatment option for fibromyalgia? Curr Psychiatry Rep 2008;10(3):237-9
PubMedGoogle Scholar
O'Malley PG, Jackson JL, Santoro J, et al. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 1999;48(12):980-90
PubMed Web of Science ®Google Scholar
Thomas MA, Smith AP. An investigation of the long-term benefits of antidepressant medication in the recovery of patients with chronic fatigue syndrome. Hum Psychopharmacol 2006;21(8):503-9
PubMed Web of Science ®Google Scholar
Hauser W, Bernardy K, Uceyler N, Sommer C. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA 2009;301(2):198-209
PubMed Web of Science ®Google Scholar
Gracious B, Wisner KL. Nortriptyline in chronic fatigue syndrome: a double blind, placebo-controlled single case study. Biol Psychiatry 1991;30(4):405-8
PubMed Web of Science ®Google Scholar
Delbanco TL, Daley J, Hartman EE. A 56-year-old woman with chronic fatigue syndrome, 1 year later. JAMA 1998;280(4):372
PubMed Web of Science ®Google Scholar
Jones JF, Straus SE. Chronic epstein-barr virus infection. Annu Rev Med 1987;38:195-209
PubMed Web of Science ®Google Scholar
Gorensek MJ. Chronic fatigue and depression in the ambulatory patient. Prim Care 1991;18(2):397-419
PubMed Web of Science ®Google Scholar
Nishishinya B, Urrutia G, Walitt B, et al. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology (Oxford) 2008;47(12):1741-6
PubMed Web of Science ®Google Scholar
Uceyler N, Hauser W, Sommer C. A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome. Arthritis Rheum 2008;59(9):1279-98
PubMed Web of Science ®Google Scholar
Hartz AJ, Bentler SE, Brake KA, Kelly MW. The effectiveness of citalopram for idiopathic chronic fatigue. J Clin Psychiatry 2003;64(8):927-35
PubMed Web of Science ®Google Scholar
Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health, 1976;218-22
Google Scholar
Amsterdam JD, Shults J, Rutherford N. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008;32(1):100-6
PubMed Web of Science ®Google Scholar
Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993;37(2):147-53
PubMed Web of Science ®Google Scholar
Fisk JD, Ritvo PG, Ross L, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994;18(Suppl 1):S79-83
PubMed Web of Science ®Google Scholar
Vercoulen JH, Swanink CM, Zitman FG, et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996;347(9005):858-61
PubMed Web of Science ®Google Scholar
Wearden AJ, Morriss RK, Mullis R, et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry 1998;172:485-90
PubMed Web of Science ®Google Scholar
Behan PO, Hhaniffah BAG, Doogan DP. A pilot study of sertraline for the treatment of chronic fatigue syndrome. Clin Infect Dis 1994;18:S111
Google Scholar
Dhir A, Kulkarni SK. Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice. Pharmacol Biochem Behav 2008;89(4):563-71
PubMed Web of Science ®Google Scholar
Goodnick PJ. Treatment of chronic fatigue syndrome with venlafaxine. Am J Psychiatry 1996;153(2):294
PubMed Web of Science ®Google Scholar
Rosenhagen MC, Schmidt U, Ebinger M, et al. Successful treatment of chronic fatigue syndrome with duloxetine and trijodthyronine–a case study. J Clin Psychopharmacol 2008;28(1):105-7
PubMed Web of Science ®Google Scholar
Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004;50(9):2974-84
PubMed Web of Science ®Google Scholar
Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005;119(1-3):5-15
PubMed Web of Science ®Google Scholar
Russell IJ, Mease PJ, Smith TR, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 2008;136(3):432-44
PubMed Web of Science ®Google Scholar
Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol 2005;32(10):1975-85
PubMed Web of Science ®Google Scholar
Vitton O, Gendreau M, Gendreau J, et al. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol 2004;19(Suppl 1):S27-35
PubMed Web of Science ®Google Scholar
Gur A, Oktayoglu P. Central nervous system abnormalities in fibromyalgia and chronic fatigue syndrome: new concepts in treatment. Curr Pharm Des 2008;14(13):1274-94
PubMed Web of Science ®Google Scholar
Stubhaug B, Lie SA, Ursin H, Eriksen HR. Cognitive-behavioural therapy v. mirtazapine for chronic fatigue and neurasthenia: randomised placebo-controlled trial. Br J Psychiatry 2008;192(3):217-23
PubMed Web of Science ®Google Scholar
Goodnick PJ, Sandoval R, Brickman A, Klimas NG. Bupropion treatment of fluoxetine-resistant chronic fatigue syndrome. Biol Psychiatry 1992;32(9):834-8
PubMed Web of Science ®Google Scholar
Schonfeldt-Lecuona C, Connemann BJ, Wolf RC, et al. Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode. Pharmacopsychiatry 2006;39(4):152-4
PubMed Web of Science ®Google Scholar
Altschuler EL, Kast RE. Bupropion for fatigue and as a tumor necrosis factor-alpha lowering agent in primary biliary cirrhosis. Med Hypotheses 2005;64(1):118-9
PubMed Web of Science ®Google Scholar
Pae CU, Lim HK, Han C, et al. Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion. Expert Rev Neurother 2007;7(10):1251-63
PubMedGoogle Scholar
Papakostas GI, Nutt DJ, Hallett LA, et al. Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry 2006;60(12):1350-5
PubMed Web of Science ®Google Scholar
White PD, Cleary KJ. An open study of the efficacy and adverse effects of moclobemide in patients with the chronic fatigue syndrome. Int Clin Psychopharmacol 1997;12(1):47-52
PubMed Web of Science ®Google Scholar
Hickie IB, Wilson AJ, Wright JM, et al. A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. J Clin Psychiatry 2000;61(9):643-8
PubMed Web of Science ®Google Scholar
Hickie I, Wilson A. A catecholamine model of fatigue. Br J Psychiatry 1994;165(2):275-6
PubMed Web of Science ®Google Scholar
Natelson BH, Cheu J, Pareja J, et al. Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome. Psychopharmacology (Berl) 1996;124(3):226-30
PubMed Web of Science ®Google Scholar
Natelson BH, Cheu J, Hill N, et al. Single-blind, placebo phase-in trial of two escalating doses of selegiline in the chronic fatigue syndrome. Neuropsychobiology 1998;37(3):150-4
PubMed Web of Science ®Google Scholar
Pae CU, Lim HK, Han C, et al. Selegiline transdermal system: current awareness and promise. Prog Neuropsychopharmacol Biol Psychiatry 2007;31(6):1153-63
PubMed Web of Science ®Google Scholar
Blacker CV, Greenwood DT, Wesnes KA, et al. Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial. JAMA 2004;292(10):1195-204
PubMed Web of Science ®Google Scholar
Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H. Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am J Med 2006;119(2):167 e23-30
Google Scholar
Bruera E, Driver L, Barnes EA, et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 2003;21(23):4439-43
PubMed Web of Science ®Google Scholar
Bruera E, Valero V, Driver L, et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 2006;24(13):2073-8
PubMed Web of Science ®Google Scholar
Olson LG, Ambrogetti A, Sutherland DC. A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome. Psychosomatics 2003;44(1):38-43
PubMed Web of Science ®Google Scholar
Randall DC, Cafferty FH, Shneerson JM, et al. Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndrome. J Psychopharmacol 2005;19(6):647-60
PubMed Web of Science ®Google Scholar
Stankoff B, Waubant E, Confavreux C, et al. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. Neurology 2005;64(7):1139-43
PubMed Web of Science ®Google Scholar
Zifko UA, Rupp M, Schwarz S, et al. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study. J Neurol 2002;249(8):983-7
PubMed Web of Science ®Google Scholar
Luyten P, Van Houdenhove B, Pae CU, et al. Treatment of chronic fatigue syndrome: findings, principles and strategies. Psychiatry Invest 2008;5:209-12
PubMed Web of Science ®Google Scholar
Pae CU, Masand PS, Ajwani N, et al. Irritable bowel syndrome in psychiatric perspectives: a comprehensive review. Int J Clin Pract 2007;61(10):1708-18
PubMed Web of Science ®Google Scholar
Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988;108(3):387-9
PubMed Web of Science ®Google Scholar
Lloyd AR, Wakefield D, Boughton C, Dwyer J. What is myalgic encephalomyelitis? Lancet 1988;1(8597):1286-7
PubMed Web of Science ®Google Scholar
Sharpe MC, Archard LC, Banatvala JE, et al. A report–chronic fatigue syndrome: guidelines for research. J R Soc Med 1991;84(2):118-21
PubMed Web of Science ®Google Scholar
Organization. WH. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. WHO; 1993
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date